Chris Reddick

Chris Reddick is a medical scientist by training and has spent more than 20 years working in healthcare to advance health equity and access to quality healthcare. Since joining Takeda in 2007, he has worked with global stakeholders, to advance Takeda’s vision and approach to Access to Medicines (AtM), Diversity, Equity and Inclusion (DE&I), Patient Centricity, and Health Equity. He is currently the Head of U.S. Health Equity with responsibility for developing and executing Takeda’s health equity strategy in the U.S. to address health disparities and inequities in communities and ensure broader patient access to Takeda’s medicines. Chris also serves as the executive sponsor of Takeda’s Black Leadership Council (BLC).